This is an outdated version published on 19-03-2023. Read the most recent version.

Forthcoming

DMPK studies in rat model for comparative evaluation of bioavailability of alpha-mangostin and its formulated solid lipid nanoparticle using a validated LC-MS/MS method

Authors

Nagendra Babu Vutti K L College of Pharmacy, Koneru Lakshmaiah Education Foundation, Vaddeswaram, Andhra Pradesh 522502, India https://orcid.org/0000-0002-6805-1440
Koteswara Rao GSN Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM’s NMIMS, V.L. Mehta Road, Vile Parle (W), Mumbai- 400056, India https://orcid.org/0000-0003-1257-7133
Rajasekhar Reddy Alavala Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM’s NMIMS, , Mumbai, Maharashtra, India https://orcid.org/0000-0002-2610-8111
Md. Jaha Sultana K L College of Pharmacy, Koneru Lakshmaiah Education Foundation, Vaddeswaram, Andhra Pradesh 522502, India https://orcid.org/0000-0002-5882-1931
Kishore Babu Govada Formulation R&D, Laila Nutraceuticals, Vijayawada, Andhra Pradesh 520007, India. https://orcid.org/0000-0001-7619-5973
CH Nagendra Formulation R&D, Laila Nutraceuticals, Vijayawada, Andhra Pradesh 520007, India. https://orcid.org/0000-0002-8400-8805
Ravi Kumar Madireddy K L College of Pharmacy, Koneru Lakshmaiah Education Foundation, Vaddeswaram, Andhra Pradesh 522502, India https://orcid.org/0000-0001-5147-6015

DOI:

https://doi.org/10.14719/pst.2217

Keywords:

Alpha-mangostin, Solid lipid nanoparticles, LC-MS/MS method, Caco-2 cell line study

Abstract

Garcinia mangostana L., contains the xanthone ?-mangostin, which is a bioactive secondary metabolite. The Caco-2 cell line transport of ?-mangostin was explored to see whether it could be used to study oral uptake. There has been little in-vivo research on the drug metabolism and pharmacokinetics of solid lipid nanoparticles of ?-mangostin. The ?-mangostin content estimation in plasma of rat was accomplished using a validated LC-MS/MS technique. The Papp (permeability coefficient apparent) across the Caco-2 cell monolayer is used to predict the absorption of orally administered ?-mangostin and ?-mangostin solid lipid nanoparticles (AM-SLNP). In the presence of the solid lipid and emulsifiers, AM-SLNP had 3.72 times higher Papp than ?-mangostin after 4 hours of study across the Caco-2 cell line. In-vivo rat model study show that formulated AM-SLNP has a 3.3-fold higher bioavailability than pure ?-mangostin. High tissue distribution of the AM-SLNP is observed compared to ?-mangostin, which may improve the efficacy of the product when compared to pure extract, as the available drug at the site of distribution is high. Because both cell monolayer and animal studies demonstrate the same pattern of drug intake mechanism for SLNP’s and as it is almost identical, nanotechnology can be utilized in avoiding hepatic metabolism and improving bioavailability.

Downloads

Download data is not yet available.

References

Morton J. Roselle. In: Fruits of Warm Climate. Julia F. Morton: Miami, FL; 1987. p. 281-286. http://www.hort.purdue.edu/newcrop/mortonne/roselle.html

Chin YW, Jung HA, Chai H, Keller WJ, Kinghorn AD. Xanthones with quinone reductase-inducing activity from the fruits of Garcinia mangostana (mangosteen). Phytochemistry. 2008; 69(3):754-8. https://doi.org/10.1016/j.phytochem.2007.09.023

Obolskiy D, Pischel I, Siriwatanametanon N, Heinrich M. Garcinia mangostana L.: a phytochemical and pharmacological review. Phytotherapy research. 2009; 23(8): 1047–1065. https://doi.org/10.1002/ptr.2730

Han AR, Kim JA, Lantvit DD, Kardono LB, Riswan S, Chai H, Carcache de Blanco EJ, Farnsworth NR, Swanson SM, Kinghorn AD. Cytotoxic xanthone constituents of the stem bark of Garcinia mangostana (mangosteen). J Nat Prod. 2009; 72(11):2028-31. https://doi.org/10.1021/np900517h

Jung HA, Su BN, Keller WJ, Mehta RG, Kinghorn AD. Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen). J Agric Food Chem. 2006; 54(6):2077-82. https://doi.org/10.1021/jf052649z

Pothitirat W, Chomnawang MT, Supabphol R, Gritsanapan W. Comparison of bioactive compounds content, free radical scavenging and anti-acne inducing bacteria activities of extracts from the mangosteen fruit rind at two stages of maturity. Fitoterapia. 2009; 80(7):442-7.https://doi.org/10.1016/j.fitote.2009.06.005

Yoshikawa M, Harada E, Miki A, Tsukamoto K, Liang SQ, Yamahara J, Murakami N. Antioxidant constituents from the fruit hulls of mangosteen (Garcinia mangostana L.) originating in Vietnam. Yakugaku Zasshi. 1994; 114: 129–133. https://www.cabi.org/isc/abstract/19940310889

Han SY, Chin YW, Choi YH. A new approach for pharmacokinetic studies of natural products: measurement of isoliquiritigenin levels in mice plasma, urine and feces using modified automated dosing/blood sampling system. Biomed Chromatogr. 2013; 27(6):741-9. https://doi.org/10.1002/bmc.2854

Chairungsrilerd N, Furukawa K, Ohta T, Nozoe S, Ohizumi Y. Histaminergic and serotonergic receptor blocking substances from the medicinal plant Garcinia mangostana. Planta Med. 1996; 62(5):471-2.. https://doi.org/10.1055/s-2006-957943

Chomnawang MT, Surassmo S, Wongsariya K, Bunyapraphatsara N. Antibacterial activity of Thai medicinal plants against methicillin-resistant Staphylococcus aureus. Fitoterapia. 2009; 80(2):102-4. https://doi.org/10.1016/j.fitote.2008.10.007

Puripattanavong J, Khajorndetkun W, Chansathirapanich W. Improved isolation of ?-mangostin from the fruit hull of Garcinia mangostana and its antioxidant and antifungal activity. Planta Medica. 2006; 72. https://doi.org/10.1055/s-2006-950128

Chen SX, Wan M, Loh BN. Active constituents against HIV-1 protease from Garcinia mangostana. Planta Med. 1996;62(4):381-2 https://doi.org/10.1055/s-2006-957916

Vlietinck AJ, De Bruyne T, Apers S, Pieters LA. Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection. Planta Med. 1998; 64(2):97-109. https://doi.org/10.1055/s-2006-957384

Balunas MJ, Su B, Brueggemeier RW, Kinghorn AD. Xanthones from the botanical dietary supplement mangosteen (Garcinia mangostana) with aromatase inhibitory activity. J Nat Prod. 2008; 71(7):1161-6. https://doi.org/10.1021/np8000255

Chin YW, Jung HA, Chai H, Keller WJ, Kinghorn AD. Xanthones with quinone reductase-inducing activity from the fruits of Garcinia mangostana (Mangosteen). Phytochemistry. 2008; 69(3):754-8. https://doi.org/10.1016/j.phytochem.2007.09.023

Chin YW, Kinghorn AD. Structural Characterization, Biological Effects, and Synthetic Studies on Xanthones from Mangosteen (Garcinia mangostana), a Popular Botanical Dietary Supplement. Mini Rev Org Chem. 2008; 5(4):355-364. https://doi.org/10.2174/157019308786242223

Nilar, Harrison LJ. Xanthones from the heartwood of Garcinia mangostana. Phytochemistry. 2002; 60(5):541-8. https://doi.org/10.1016/s0031-9422(02)00142-5

Suksamrarn S, Suwannapoch N, Ratananukul P, Aroonlerk N, Suksamrarn A. Xanthones from the green fruit hulls of Garcinia mangostana. Journal of natural products. 2002; 65(5): 761–763. https://doi.org/10.1021/np010566g

Peres V, Nagem TJ, de Oliveira FF. Tetraoxygenated naturally occurring xanthones. Phytochemistry. 2000; 55(7):683-710. https://doi.org/10.1016/s0031-9422(00)00303-4

Walker EB. HPLC analysis of selected xanthones in mangosteen fruit. J Sep Sci. 2007; 30(9):1229-34. https://doi.org/10.1002/jssc.200700024

Devi Sampath P, Vijayaraghavan K. Cardioprotective effect of alpha-mangostin, a xanthone derivative from mangosteen on tissue defense system against isoproterenol-induced myocardial infarction in rats. J Biochem Mol Toxicol. 2007; 21(6):336-9. https://doi.org/10.1002/jbt.20199

Gopalakrishnan C, Shankaranarayanan D, Kameswaran L, Nazimudeen SK. Effect of mangostin, a xanthone from Garcinia mangostana Linn. in immunopathological & inflammatory reactions. Indian J Exp Biol. 1980; 18(8):843-6. https://pubmed.ncbi.nlm.nih.gov/7461736/

Nakagawa Y, Iinuma M, Naoe T, Nozawa Y, Akao Y. Characterized mechanism of alpha-mangostin-induced cell death: caspase-independent apoptosis with release of endonuclease-G from mitochondria and increased miR-143 expression in human colorectal cancer DLD-1 cells. Bioorg Med Chem. 2007; 15(16):5620-8. https://doi.org/10.1016/j.bmc.2007.04.071

Sakagami Y, Iinuma M, Piyasena KG, Dharmaratne HR. Antibacterial activity of alpha-mangostin against vancomycin resistant Enterococci (VRE) and synergism with antibiotics. Phytomedicine. 2005; 12(3):203-8.https://doi.org/10.1016/j.phymed.2003.09.012

Sampath PD, Vijayaragavan K. Ameliorative prospective of alpha-mangostin, a xanthone derivative from Garcinia mangostana against beta-adrenergic cathecolamine-induced myocardial toxicity and anomalous cardiac TNF-alpha and COX-2 expressions in rats. Exp Toxicol Pathol. 2008; 60(4-5):357-64.https://doi.org/10.1016/j.etp.2008.02.006

Sampath PD, Kannan V. Mitigation of mitochondrial dysfunction and regulation of eNOS expression during experimental myocardial necrosis by alpha-mangostin, a xanthonic derivative from Garcinia mangostana. Drug Chem Toxicol. 2009;32(4):344-52 https://doi.org/10.1080/01480540903159210

Kondo M, Zhang L, Ji H, Kou Y, Ou B. Bioavailability and antioxidant effects of a xanthone-rich mangosteen (Garcinia mangostana) product in humans. J Agric Food Chem. 2009; 57(19):8788-92. https://doi.org/10.1021/jf901012f

Han SY, Chin YW, Kim DY, Choi YH. Simultaneous determination of ?- and-? mangostins in mouse plasma by HPLC-MS/MS method: application to a pharmacokinetic study of mangosteen extract in mouse. Chromatographia. 2013; 76: 643–650. https://doi.org/10.1007/s10337-013-2437-3

Downloads

Published

19-03-2023

Versions

01-04-2023 (2)
19-03-2023 (1)

How to Cite

Vutti NB, GSN KR, Alavala RR, Sultana MJ, Govada KB, Nagendra C, Madireddy RK. DMPK studies in rat model for comparative evaluation of bioavailability of alpha-mangostin and its formulated solid lipid nanoparticle using a validated LC-MS/MS method. Plant Sci. Today [Internet]. 2023 Mar. 19 [cited 2024 Nov. 24];. Available from: https://horizonepublishing.com/journals/index.php/PST/article/view/2217

Download Citation

Issue

Early Access

Section

Research Articles

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright and Licence details of published articles

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Open Access Policy

Plant Science Today is an open access journal. There is no registration required to read any article. All published articles are distributed under the terms of the Creative Commons Attribution License (CC Attribution 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited (https://creativecommons.org/licenses/by/4.0/). Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).